Chronic subdural hematoma has been reported as one of the complications of childhood acute lymphocytic leukemia (ALL), acute promyelocytic leukemia (APL) and chronic myelogenous leukemia (CML) in the blastic phase [1][2][3][4]. We report a case with CML who developed subdural hematoma during bone marrow transplantation (BMT). A 24-year-old male was diagnosed as having Philadelphia-chromosome-positive CML in 1989. After having been treated with α interferon and hydroxyurea for 2 years, he underwent allogeneic BMT in June 1991 using busulfan and cyclophosphamide as a preparative regimen. The last preoperative bone marrow examination was performed on day -12 of BMT which revealed less than 2% of blasts and promyelocytes. Intrathecal treatment with methotrexate and cytosine arabinoside was performed on day -11 of BMT with normal findings of cerebrospinal fluid. Phenytoin had also been used as prophylaxis for neurological toxicity of busulfan. On the second day of busulfan, day -6 of BMT, he started to complain of headache on his forehead. Neurological examination was normal, and CT scanning of the whole brain performed on the same day did not show any abnormalities ( fig. la) . His serum level of phenytoin was within normal limits, and so were the coagulation studies. Because his symptoms seemed to be subsiding, he underwent BMT as scheduled. The post-BMT hospital course was unremarkable except for an episode of fever, which responded to antibiotics, and the exacerbating headache which restarted on day 1 without any history of head injury. Multiple neurological examinations including the examinations of his optic fundi had been persistently normal. His platelet counts had been maintained above 20 × 109/1 during the whole course of the BMT, and the coagulation studies also remained normal. A repeated CT scan of the brain was obtained on day 17 after the engraft -ment of the bone marrow had been confirmed, which revealed bilateral diffuse subdural hematoma and brain edema ( fig. lb) . Because of the low platelet and the neutrophil counts, he was followed with medical treatment and then underwent a drainage operation of the bilateral subdural hematoma on day 34. His
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